Olmesartan medoxomil combined with hydrochlorothiazide improves 24-hour blood pressure control in moderate-to-severe hypertension

By Rosenbaum David   Girerd Xavier  

Current Medical Research and Opinion, Vol. 28, Iss. 2, 2012-02 ,pp. : 179-186

Informa Healthcare

Access to resources Recommend Favorite

Health economic implications of irbesartan treatment versus standard blood pressure control in patients with type 2 diabetes, hypertension and renal disease: a Hungarian analysis

By Palmer Andrew   Valentine William   Ray Joshua   Roze Stephane   Muszbek Noemi  

The European Journal of Health Economics, Vol. 8, Iss. 2, 2007-06 ,pp. : 161-168

Springer Publishing Company

Access to resources Recommend Favorite

A cluster randomised controlled trial of the effect of a treatment algorithm for hypertension in patients with type 2 diabetes

By Bebb Charlotte   Kendrick Denise   Coupland Carol   Madeley Richard   Stewart Jane   Brown Ken   Burden Richard   Sturrock Nigel  

British Journal of General Practice, Vol. 57, Iss. 535, 2007-02 ,pp. : 136-143

Royal College of General Practitioners

Access to resources Recommend Favorite

Effects of a Slow-Release Nifedipine on 24-Hour Ambulatory Blood Pressure and Ischemic Changes on 24-Hour Ambulatory Electrocardiogram in Patients with Severe Coronary Artery Disease

By  

Cardiology, Vol. 94, Iss. 1, 2000-11 ,pp. : 36-43

Karger

Access to resources Recommend Favorite

Effects of empagliflozin on blood pressure and markers of arterial stiffness and vascular resistance in patients with type 2 diabetes

By  

DIABETES OBESITY & METABOLISM (ELECTRONIC), Vol. 17, Iss. 12, 2015-12 ,pp. : 1180-1193

John Wiley & Sons Inc

Access to resources Recommend Favorite